Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions

Andreas Doesch, Li Zhao, Christian Gleissner, Mohammadreza Akhavanpoor, David Rohde, Deniz Okuyucu, Maani Hakimi, Hugo A. Katus, Christian Erbel, Thomas Dengler
  • Drug Design Development and Therapy, May 2014, Taylor & Francis
  • DOI: 10.2147/dddt.s59594

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Christian Gleißner and Dr Mohammadreza Akhavanpoor